International Society For Pharmaceutical Engineering Sponsors Special PQLI Session At IFPAC's Annual Meeting

Main Category: Pharma Industry / Biotech Industry
Also Included In: Medical Devices / Diagnostics
Article Date: 27 Nov 2008 - 1:00 PDT

email to a friend   printer friendly   opinions  

ISPE, a global not-for-profit association of 25,000 pharmaceutical science and manufacturing professionals, will sponsor a special session on its Product Quality Lifecycle ImplementationTM (PQLI) initiative during IFPAC's 23rd International Forum and Exhibition, IFPAC-09.

Themed, "Operational Excellence through Process Understanding and Control…Facing Today's Challenges," IFPAC's meeting will be held January 25-28 at the Baltimore Marriott Waterfront Hotel in Baltimore, Maryland, USA. During the event, IFPAC will offer a full 3.5-day meeting on Process Analytical Technology (PAT) and Quality by Design initiatives. Featuring more than 150 presenters in a curriculum with over 20 sessions, the IFPAC-09 program promotes multi-industry dialogue and allows for the discussion of PAT's real-life applications. A number of leading PAT/QbD case studies/applications within the pharmaceutical and biotechnology industry will be presented. Representatives from Novartis, Eli Lilly, Pfizer, Wyeth Pharmaceuticals, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, and Merck will discuss several of these applications.

Launched in June of 2007, ISPE's PQLI initiative is an effort to help the pharmaceutical industry find practical, global approaches to implementing ICH guidances Q8, Q9, and Q10. ISPE's session on PQLI will take place on Monday afternoon, 26 January and will include discussions led by industry leaders from Abbott Labs, AstraZeneca, GlaxoSmithKline, and Wyeth Pharmaceuticals, with case studies and panel discussions to follow.

For more information, and to register for IFPAC-09, visit http://www.ifpac09.org.

About ISPE

ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 25,000 pharmaceutical science and manufacturing professionals in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop technical knowledge, exchange practical experience, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE has worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; its Asia Pacific office in Singapore; and its newly established office in Shanghai, China. Visit http://www.ISPE.org for additional Society news and information.

About IFPAC

The International Foundation Process Analytical Chemistry (IFPAC) is a world-wide, not-for-profit organization dedicated to the advancement of Process Analytical Technology and Chemistry. IFPAC provides a dynamic platform for the interaction of ideas and sharing of information between industry, research institutions, government agencies, and the manufacturers/suppliers of Process Analytical Chemistry and Technology with the ultimate goal of understanding and controlling the manufacturing process. The organization promotes and advances the key components and benefits of innovative manufacturing and continuous quality assurance. Visit http://www.ifpacnet.org for more information.

IFPAC

• Additional
• References
• Citations